<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35891272</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>11</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Potential Immunologic and Integrative Methods to Enhance Vaccine Safety.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1108</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines10071108</ELocationID><Abstract><AbstractText>Vaccine safety is measured by the disease protection it confers compared to the harm it may cause; both factors and their relative numbers have been the subject of disagreement. Cross-reactive attack of analogous self-antigens modified by dietary and microbiome factors is one of the poorly explored likely causes of harm. Screening for that and other risk factors might point out those most likely to develop severe vaccine reactions. Cooperation from those with opinions for and against vaccination in data gathering and vetting will lead to greater safety. Screening should include an integrative medical perspective regarding diet, microbiome, leaky gut, and other antigen sources. It might include emerging electronic technology or integrative energetic techniques vetted ultimately by cross-reactive lymphocyte testing or genetic evaluation. The knowledge gained from evaluating those with reactions could enhance the screening process and, since similar antigenic stimuli and reactions are involved, help long COVID sufferers. Centers for early identification and rescue from vaccine reactions could lower morbidity and mortality, and increase the percentage of people choosing to be vaccinated. Additional platforms for boosting; using lower dosage; other routes of administration, such as intranasal or intradermal needles; and possibly different antigens could make it easier to vaccinate globally to address the new variants of viruses rapidly arising.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dattner</LastName><ForeName>Alan M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Integrative Dermatology and Medicine, Sarasota, FL 34231, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cross-reactivity</Keyword><Keyword MajorTopicYN="N">integrative medicine</Keyword><Keyword MajorTopicYN="N">leaky gut</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">lower dosage</Keyword><Keyword MajorTopicYN="N">screening</Keyword><Keyword MajorTopicYN="N">vaccine safety</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35891272</ArticleId><ArticleId IdType="pmc">PMC9322796</ArticleId><ArticleId IdType="doi">10.3390/vaccines10071108</ArticleId><ArticleId IdType="pii">vaccines10071108</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Biswas N., Mustapha T., Khubchandani J., Price J.H. The Nature and Extent of COVID-19 Vaccination Hesitancy in Healthcare Workers. J. Community Health. 2021;46:1244&#x2013;1251. doi: 10.1007/s10900-021-00984-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10900-021-00984-3</ArticleId><ArticleId IdType="pmc">PMC8056370</ArticleId><ArticleId IdType="pubmed">33877534</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand P., Stahel V.P. The safety of COVID-19 mRNA vaccines: A review. Patient Saf. Surg. 2021;15:20. doi: 10.1186/s13037-021-00291-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13037-021-00291-9</ArticleId><ArticleId IdType="pmc">PMC8087878</ArticleId><ArticleId IdType="pubmed">33933145</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitiello A., Ferrara F. Brief review of the mRNA vaccines COVID-19. Inflammopharmacology. 2021;29:645&#x2013;649. doi: 10.1007/s10787-021-00811-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00811-0</ArticleId><ArticleId IdType="pmc">PMC8087898</ArticleId><ArticleId IdType="pubmed">33932192</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong M., Kshirsagar M., Johnston R., Dodhia R., Glazer T., Kim A., Michael D., Nair-Desai S., Tsai T.C., Friedhoff S., et al. Estimating Vaccine-Preventable COVID-19 Deaths Under Counterfactual Vaccination Scenarios in the United States. medRxiv. 2022 doi: 10.1101/2022.05.19.22275310. in preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.19.22275310</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg R.K., Paliwal V.K. Spectrum of neurological complications following COVID-19 vaccination. Neurol. Sci. 2022;43:3&#x2013;40. doi: 10.1007/s10072-021-05662-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05662-9</ArticleId><ArticleId IdType="pmc">PMC8557950</ArticleId><ArticleId IdType="pubmed">34719776</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassauni&#xe8;re R., Polacek C., Frische A., Boding L., S&#xe6;kmose S.G., Rasmussen M., Fomsgaard A. Neutralizing Antibodies Against the SARS-CoV-2 Omicron Variant (BA.1) 1 to 18 Weeks After the Second and Third Doses of the BNT162b2 mRNA Vaccine. JAMA Netw. Open. 2022;5:e2212073. doi: 10.1001/jamanetworkopen.2022.12073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.12073</ArticleId><ArticleId IdType="pmc">PMC9107029</ArticleId><ArticleId IdType="pubmed">35560054</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai C., Peng Y., Shen E., Huang Q., Chen Y., Liu P., Guo C., Feng Z., Gao L., Zhang X., et al. A comprehensive analysis of the efficacy and safety of COVID-19 vaccines. Mol. Ther. 2021;29:2794&#x2013;2805. doi: 10.1016/j.ymthe.2021.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2021.08.001</ArticleId><ArticleId IdType="pmc">PMC8342868</ArticleId><ArticleId IdType="pubmed">34365034</ArticleId></ArticleIdList></Reference><Reference><Citation>Conklin L., Hviid A., Orenstein W.A., Pollard A.J., Wharton M., Zuber P. Vaccine safety issues at the turn of the 21st century. BMJ Glob. Health. 2021;6:e004898. doi: 10.1136/bmjgh-2020-004898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2020-004898</ArticleId><ArticleId IdType="pmc">PMC8137241</ArticleId><ArticleId IdType="pubmed">34011504</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai D., Yip B.H.K., Windham G.C., Sourander A., Francis R., Yoffe R., Glasson E., Mahjani B., Suominen A., Leonard H., et al. Association of Genetic and Environmental Factors with Autism in a 5-Country Cohort. JAMA Psychiatry. 2019;76:1035&#x2013;1043. doi: 10.1001/jamapsychiatry.2019.1411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2019.1411</ArticleId><ArticleId IdType="pmc">PMC6646998</ArticleId><ArticleId IdType="pubmed">31314057</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 17 May 2022)].  Available online:  https://www.medalerts.org/vaersdb/findfield.php?TABLE=ON&amp;GROUP1=CAT&amp;EVENTS=ON&amp;VAX=COVID19.</Citation></Reference><Reference><Citation> [(accessed on 17 May 2022)].  Available online:  https://www.medpagetoday.com/special-reports/exclusives/98762?</Citation></Reference><Reference><Citation>Persad G., Pandya A. A Comprehensive COVID-19 Response&#x2014;The Need for Economic Evaluation. N. Engl. J. Med. 2022;386:2449&#x2013;2451. doi: 10.1056/NEJMp2202828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2202828</ArticleId><ArticleId IdType="pubmed">35507511</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina V., Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity. 2005;38:235&#x2013;245. doi: 10.1080/08916930500050277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930500050277</ArticleId><ArticleId IdType="pubmed">16126512</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaevert J.A., Duque D.L., Lythe G., Molina-Par&#xed;s C., Thomas P.G. Quantifying T Cell Cross-Reactivity: Influenza and Coronaviruses. Viruses. 2021;13:1786. doi: 10.3390/v13091786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13091786</ArticleId><ArticleId IdType="pmc">PMC8472275</ArticleId><ArticleId IdType="pubmed">34578367</ArticleId></ArticleIdList></Reference><Reference><Citation>Goriely S., Goldman M. From Tolerance to Autoimmunity: Is There a Risk in Early Life Vaccination? J. Comp. Pathol. 2007;137:S57&#x2013;S61. doi: 10.1016/j.jcpa.2007.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcpa.2007.04.013</ArticleId><ArticleId IdType="pubmed">17548092</ArticleId></ArticleIdList></Reference><Reference><Citation>Dattner A.M., Mann D.L., Levis W.R. Studies on the Contact Sensitization of Man with Simple Chemicals: V. Clonal Priming Allows Direct in vitro Assessment of Autologous HLA-associated Factors Required for Immune Response to Dinitrochlorobenzene. J. Investig. Dermatol. 1979;73:246&#x2013;249. doi: 10.1111/1523-1747.ep12514334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1523-1747.ep12514334</ArticleId><ArticleId IdType="pubmed">89174</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae S., Lee Y.W., Lim S.Y., Lee J.-H., Lim J.S., Lee S., Park S., Kim S.-K., Lim Y.-J., Kim E.O., et al. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea. J. Korean Med. Sci. 2021;36:e115. doi: 10.3346/jkms.2021.36.e115.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2021.36.e115</ArticleId><ArticleId IdType="pmc">PMC8093607</ArticleId><ArticleId IdType="pubmed">33942579</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh T.H., Woo S.H., Hong S., Lee C., Lee W.J., Jeong S.K. Clinical Features of Patients Presenting to the Emergency Department with Cardiovascular Adverse Reactions After COVID-19 mRNA Vaccination. J. Korean Med. Sci. 2022;37:e73. doi: 10.3346/jkms.2022.37.e73.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2022.37.e73</ArticleId><ArticleId IdType="pmc">PMC8901880</ArticleId><ArticleId IdType="pubmed">35257528</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery J., Ryan M., Engler R., Hoffman D., McClenathan B., Collins L., Loran D., Hrncir D., Herring K., Platzer M., et al. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiol. 2021;6:1202. doi: 10.1001/jamacardio.2021.2833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2833</ArticleId><ArticleId IdType="pmc">PMC8243257</ArticleId><ArticleId IdType="pubmed">34185045</ArticleId></ArticleIdList></Reference><Reference><Citation>Hali F., Araqi L., Marnissi F., Meftah A., Chiheb S. Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Series of Five Cases. Cureus. 2022;14:e23127. doi: 10.7759/cureus.23127.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.23127</ArticleId><ArticleId IdType="pmc">PMC9004698</ArticleId><ArticleId IdType="pubmed">35425676</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilotta C., Perrone G., Adelfio V., Spatola G.F., Uzzo M.L., Argo A., Zerbo S. COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis. Front. Immunol. 2021;12:729251. doi: 10.3389/fimmu.2021.729251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.729251</ArticleId><ArticleId IdType="pmc">PMC8666479</ArticleId><ArticleId IdType="pubmed">34912330</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriwastava S., Sharma K., Khalid S.H., Bhansali S., Shrestha A.K., Elkhooly M., Srivastava S., Khan E., Jaiswal S., Wen S. COVID-19 Vaccination and Neurological Manifestations: A Review of Case Reports and Case Series. Brain Sci. 2022;12:407. doi: 10.3390/brainsci12030407.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12030407</ArticleId><ArticleId IdType="pmc">PMC8946610</ArticleId><ArticleId IdType="pubmed">35326363</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunawardana H., Romero T., Yao N., Heidt S., Mulder A., Elashoff D.A., Valenzuela N.M. Tissue-specific endothelial cell heterogeneity contributes to unequal inflammatory responses. Sci. Rep. 2021;11:1949. doi: 10.1038/s41598-020-80102-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80102-w</ArticleId><ArticleId IdType="pmc">PMC7820348</ArticleId><ArticleId IdType="pubmed">33479269</ArticleId></ArticleIdList></Reference><Reference><Citation>Minami T., Muramatsu M., Kume T. Organ/Tissue-Specific Vascular Endothelial Cell Heterogeneity in Health and Disease. Biol. Pharm. Bull. 2019;42:1609&#x2013;1619. doi: 10.1248/bpb.b19-00531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b19-00531</ArticleId><ArticleId IdType="pubmed">31582649</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal J.P., Mak J.W.Y., Mullish B.H., Alexander J.L., Ng S.C., Marchesi J.R. The gut microbiome: An under-recognised contributor to the COVID-19 pandemic? Ther. Adv. Gastroenterol. 2020;13:1756284820974914. doi: 10.1177/1756284820974914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756284820974914</ArticleId><ArticleId IdType="pmc">PMC7692338</ArticleId><ArticleId IdType="pubmed">33281941</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H., James E.A. Immune recognition of citrullinated epitopes. Immunology. 2016;149:131&#x2013;138. doi: 10.1111/imm.12640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12640</ArticleId><ArticleId IdType="pmc">PMC5011684</ArticleId><ArticleId IdType="pubmed">27531825</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M.-L., Sodr&#xe9; F.M.C., Mamula M.J., Overbergh L. Citrullination and PAD Enzyme Biology in Type 1 Diabetes&#x2013;Regulators of Inflammation, Autoimmunity, and Pathology. Front. Immunol. 2021;12:678953. doi: 10.3389/fimmu.2021.678953.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.678953</ArticleId><ArticleId IdType="pmc">PMC8204103</ArticleId><ArticleId IdType="pubmed">34140951</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Ruan P., Wang L., Nie X., Ma X., Tan Y. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research. J. Cell. Mol. Med. 2021;25:1274&#x2013;1289. doi: 10.1111/jcmm.16200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.16200</ArticleId><ArticleId IdType="pmc">PMC7812294</ArticleId><ArticleId IdType="pubmed">33325143</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinashi Y., Hase K. Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity. Front. Immunol. 2021;12:673708. doi: 10.3389/fimmu.2021.673708.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.673708</ArticleId><ArticleId IdType="pmc">PMC8100306</ArticleId><ArticleId IdType="pubmed">33968085</ArticleId></ArticleIdList></Reference><Reference><Citation>Dwivedi N., Radic M. Citrullination of autoantigens implicates NETosis in the induction of autoimmunity. Ann. Rheum. Dis. 2014;73:483&#x2013;491. doi: 10.1136/annrheumdis-2013-203844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-203844</ArticleId><ArticleId IdType="pubmed">24291655</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenning M., Marklein B., Ytterberg J., Zubarev R.A., Joshua V., van Schaardenburg D., van de Stadt L., Catrina A.I., Nonhoff U., H&#xe4;upl T., et al. Bacterial citrullinated epitopes generated by Porphyromonas gingivalis infection&#x2014;A missing link for ACPA production. Ann. Rheum. Dis. 2020;79:1194&#x2013;1202. doi: 10.1136/annrheumdis-2019-216919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-216919</ArticleId><ArticleId IdType="pubmed">32532752</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan H., Zingarelli B., Harris V., Tempel G.E., Halushka P.V., Cook J.A. Lysophosphatidic Acid Inhibits Bacterial Endotoxin-Induced Pro-Inflammatory Response: Potential Anti-Inflammatory Signaling Pathways. Mol. Med. 2008;14:422&#x2013;428. doi: 10.2119/2007-00106.Fan.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/2007-00106.Fan</ArticleId><ArticleId IdType="pmc">PMC2323339</ArticleId><ArticleId IdType="pubmed">18431464</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrama D., Mahita J., Sette A., Peters B. Lack of evidence of significant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens. eBioMedicine. 2022;75:103807. doi: 10.1016/j.ebiom.2021.103807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103807</ArticleId><ArticleId IdType="pmc">PMC8733122</ArticleId><ArticleId IdType="pubmed">34998242</ArticleId></ArticleIdList></Reference><Reference><Citation>Husby A., Hansen J.V., Fosb&#xf8;l E., Thiesson E.M., Madsen M., Thomsen R.W., S&#xf8;rensen H.T., Andersen M., Wohlfahrt J., Gislason G., et al. SARS-CoV-2 vaccination and myocarditis or myopericarditis: Population based cohort study. BMJ. 2021;375:e068665. doi: 10.1136/bmj-2021-068665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068665</ArticleId><ArticleId IdType="pmc">PMC8683843</ArticleId><ArticleId IdType="pubmed">34916207</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymans S., Cooper L.T. Myocarditis after COVID-19 mRNA vaccination: Clinical observations and potential mechanisms. Nat. Rev. Cardiol. 2022;19:75&#x2013;77. doi: 10.1038/s41569-021-00662-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00662-w</ArticleId><ArticleId IdType="pmc">PMC8656440</ArticleId><ArticleId IdType="pubmed">34887571</ArticleId></ArticleIdList></Reference><Reference><Citation>Gifre-Renom L., Daems M., Luttun A., Jones E.A.V. Organ-Specific Endothelial Cell Differentiation and Impact of Microenvironmental Cues on Endothelial Heterogeneity. Int. J. Mol. Sci. 2022;23:1477. doi: 10.3390/ijms23031477.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031477</ArticleId><ArticleId IdType="pmc">PMC8836165</ArticleId><ArticleId IdType="pubmed">35163400</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker J.A., Ovsyannikova I.G., Poland G.A. Adversomics: A new paradigm for vaccine safety and design. Expert Rev. Vaccines. 2015;14:935&#x2013;947. doi: 10.1586/14760584.2015.1038249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2015.1038249</ArticleId><ArticleId IdType="pmc">PMC4630804</ArticleId><ArticleId IdType="pubmed">25937189</ArticleId></ArticleIdList></Reference><Reference><Citation>Twardowska A., Makaro A., Binienda A., Fichna J., Salaga M. Preventing Bacterial Translocation in Patients with Leaky Gut Syndrome: Nutrition and Pharmacological Treatment Options. Int. J. Mol. Sci. 2022;23:3204. doi: 10.3390/ijms23063204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23063204</ArticleId><ArticleId IdType="pmc">PMC8949204</ArticleId><ArticleId IdType="pubmed">35328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Dattner A.M. Holistic and Integrative Methods for Diagnosing and Treating the Underlying Causes of Inflammatory Skin Diseases. J. Drugs Dermatol. 2021;20:1121&#x2013;1125. doi: 10.36849/JDD.6496.</Citation><ArticleIdList><ArticleId IdType="doi">10.36849/JDD.6496</ArticleId><ArticleId IdType="pubmed">34636518</ArticleId></ArticleIdList></Reference><Reference><Citation>Dattner A.M. Radiant Skin from the Inside Out: The Dermatologist&#x2019;s Holistic Guide to Healing Your Skin Naturaly. Picture Health Press; Sarasota, FL, USA: 2015. pp. 139&#x2013;160.</Citation></Reference><Reference><Citation>Owji S., Han J., He H., Lopera I., Tassavor M., Brownstone N., Gulati N., Ungar B., Ungar J. Diagnostic Efficacy of Electrical Impedance Spectroscopy Versus Dermoscopy for Pigmented Skin Lesions: A Pilot Study. Ski. J. Cutan. Med. 2022;6:210&#x2013;216. doi: 10.25251/skin.6.3.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.25251/skin.6.3.5</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirbeik A., Ashinoff R., Jong T., Aued A., Tavassolian N. Real-time high-resolution millimeter-wave imaging for in-vivo skin cancer diagnosis. Sci. Rep. 2022;12:4971. doi: 10.1038/s41598-022-09047-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-09047-6</ArticleId><ArticleId IdType="pmc">PMC8943071</ArticleId><ArticleId IdType="pubmed">35322133</ArticleId></ArticleIdList></Reference><Reference><Citation>Stasiak M., Zawadzka-Starczewska K., Lewi&#x144;ski A. Significance of HLA Haplotypes in Two Patients with Subacute Thyroiditis Triggered by mRNA-Based COVID-19 Vaccine. Vaccines. 2022;10:280. doi: 10.3390/vaccines10020280.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020280</ArticleId><ArticleId IdType="pmc">PMC8879821</ArticleId><ArticleId IdType="pubmed">35214738</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitkov L., Hannig M., Minnich B., Herrmann M. Periodontal sources of citrullinated antigens and TLR agonists related to RA. Autoimmunity. 2018;51:304&#x2013;309. doi: 10.1080/08916934.2018.1527907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916934.2018.1527907</ArticleId><ArticleId IdType="pubmed">30417696</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennigs J.K., Matuszcak C., Trepel M., K&#xf6;rbelin J. Vascular Endothelial Cells: Heterogeneity and Targeting Approaches. Cells. 2021;10:2712. doi: 10.3390/cells10102712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10102712</ArticleId><ArticleId IdType="pmc">PMC8534745</ArticleId><ArticleId IdType="pubmed">34685692</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Azor&#xed;n D., Do T.P., Gantenbein A.R., Hansen J.M., Souza M.N.P., Obermann M., Pohl H., Schankin C.J., Schytz H.W., Sinclair A., et al. Delayed headache after COVID-19 vaccination: A red flag for vaccine induced cerebral venous thrombosis. J. Headache Pain. 2021;22:108. doi: 10.1186/s10194-021-01324-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-021-01324-5</ArticleId><ArticleId IdType="pmc">PMC8446734</ArticleId><ArticleId IdType="pubmed">34535076</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C.-Y., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran J.P., Pinero J.C., Zheng Y., Palma N.A., Wingertzahn M. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: A structured summary of a study protocol for a randomized controlled study. Trials. 2021;22:245. doi: 10.1186/s13063-021-05157-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05157-0</ArticleId><ArticleId IdType="pmc">PMC8017509</ArticleId><ArticleId IdType="pubmed">33810796</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccioni A., Saviano A., Cicchinelli S., Franza L., Rosa F., Zanza C., Santoro M.C., Candelli M., Covino M., Nannini G., et al. Microbiota and Myopericarditis: The New Frontier in the Car-Diological Field to Prevent or Treat Inflammatory Cardiomyo-Pathies in COVID-19 Outbreak. Biomedicines. 2021;9:1234. doi: 10.3390/biomedicines9091234.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9091234</ArticleId><ArticleId IdType="pmc">PMC8468627</ArticleId><ArticleId IdType="pubmed">34572420</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S., Shafiei M.S., Longoria C., Schoggins J., Savani R.C., Zaki H. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-&#x3ba;B pathway. bioRxiv. 2021 doi: 10.1101/2021.03.16.435700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.16.435700</ArticleId><ArticleId IdType="pmc">PMC8709575</ArticleId><ArticleId IdType="pubmed">34866574</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Cao Z., Xie X., Zhang X., Chen J.Y.-C., Wang H., Menachery V.D., Rajsbaum R., Shi P.-Y. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 2020;33:108234. doi: 10.1016/j.celrep.2020.108234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108234</ArticleId><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth A., Chan P.S., Jonas W. Addressing the Long COVID Crisis: Integrative Health and Long COVID. Glob. Adv. Health Med. 2021;10:21649561211056597. doi: 10.1177/21649561211056597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21649561211056597</ArticleId><ArticleId IdType="pmc">PMC8606968</ArticleId><ArticleId IdType="pubmed">34820152</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Wu T., Xie H., Li Y., Zhang J., Su X., Qi H. The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines. Vaccines. 2022;10:1103. doi: 10.3390/vaccines10071103.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10071103</ArticleId><ArticleId IdType="pmc">PMC9324880</ArticleId><ArticleId IdType="pubmed">35891267</ArticleId></ArticleIdList></Reference><Reference><Citation>Dattner A.M., Martiniuk F., Levis W.R. In Vitro Clonal Priming Data Suggests Mechanism for Lower Initial Vaccine Dose Yielding Increased Immunity in Astra-Zeneca Vaccine Trial. J. Drugs Dermatol. 2021;20:483&#x2013;484. doi: 10.36849/JDD.6003.</Citation><ArticleIdList><ArticleId IdType="doi">10.36849/JDD.6003</ArticleId><ArticleId IdType="pubmed">33852236</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateus J., Dan J.M., Zhang Z., Moderbacher C.R., Lammers M., Goodwin B., Sette A., Crotty S., Weiskopf D. Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells. Science. 2021;374:eabj9853. doi: 10.1126/science.abj9853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj9853</ArticleId><ArticleId IdType="pmc">PMC8542617</ArticleId><ArticleId IdType="pubmed">34519540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan A.O., Kafai N.M., Dmitriev I.P., Fox J.M., Smith B.K., Harvey I.B., Chen R.E., Winkler E.S., Wessel A.W., Case J.B., et al. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2. Cell. 2020;183:169&#x2013;184.e13. doi: 10.1016/j.cell.2020.08.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.026</ArticleId><ArticleId IdType="pmc">PMC7437481</ArticleId><ArticleId IdType="pubmed">32931734</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao T., Israelow B., Suberi A., Zhou L., Reschke M., Pe&#xf1;a-Hern&#xe1;ndez M.A., Dong H., Homer R.J., Saltzman W.M. Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses. bioRxiv. 2022 doi: 10.1101/2022.01.24.477597. in preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.24.477597</ArticleId><ArticleId IdType="pmc">PMC9798903</ArticleId><ArticleId IdType="pubmed">36302057</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouphael N.G., Paine M., Mosley R., Henry S., McAllister D.V., Kalluri H., Pewin W., Frew P.M., Yu T., Thornburg N.J., et al. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): A randomised, partly blinded, placebo-controlled, phase 1 trial. Lancet. 2017;390:649&#x2013;658. doi: 10.1016/S0140-6736(17)30575-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)30575-5</ArticleId><ArticleId IdType="pmc">PMC5578828</ArticleId><ArticleId IdType="pubmed">28666680</ArticleId></ArticleIdList></Reference><Reference><Citation>Billeskov R., Beikzadeh B., Berzofsky J.A. The effect of antigen dose on T cell-targeting vaccine outcome. Hum. Vaccin Immunother. 2019;15:407&#x2013;411. doi: 10.1080/21645515.2018.1527496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2018.1527496</ArticleId><ArticleId IdType="pmc">PMC6422501</ArticleId><ArticleId IdType="pubmed">30277831</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>